Three-year results following regenerative periodontal surgery of advanced intrabony defects with enamel matrix derivative alone or combined with a synthetic bone graft

[1]  M. Paolantonio,et al.  Enamel matrix derivative, alone or associated with a synthetic bone substitute, in the treatment of 1- to 2-wall periodontal defects. , 2013, Journal of periodontology.

[2]  K. Nagy,et al.  Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate , 2012, Clinical Oral Investigations.

[3]  P. Eickholz,et al.  A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months. , 2011, Journal of clinical periodontology.

[4]  S. Milani,et al.  120 infrabony defects treated with regenerative therapy: long-term results. , 2011, Journal of periodontology.

[5]  A. Sculean,et al.  Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone. , 2010, Journal of clinical periodontology.

[6]  M. Nunn,et al.  Prospective assessment of the use of enamel matrix derivative with minimally invasive surgery: 6-year results. , 2010, Journal of periodontology.

[7]  P. Coulthard,et al.  Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. , 2010, The Cochrane database of systematic reviews.

[8]  S. Fickl,et al.  Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial. , 2009, Journal of periodontology.

[9]  P. Coulthard,et al.  Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects. , 2009, The Cochrane database of systematic reviews.

[10]  F. Schwarz,et al.  Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects. , 2008, Journal of periodontology.

[11]  L. Trombelli,et al.  Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration. , 2008, Journal of clinical periodontology.

[12]  T. Hoffmann,et al.  Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EMD alone: a multicentre randomized-controlled clinical trial. , 2008, Journal of clinical periodontology.

[13]  F. Schwarz,et al.  Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral. , 2008, The International journal of periodontics & restorative dentistry.

[14]  M. Dard,et al.  Evaluation of a novel biphasic calcium phosphate in standardized bone defects: a histologic and histomorphometric study in the mandibles of minipigs. , 2007, Clinical oral implants research.

[15]  A. Sculean,et al.  Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass. , 2007, Journal of clinical periodontology.

[16]  L. Trombelli,et al.  Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects. , 2007, Journal of periodontology.

[17]  U. Schlagenhauf,et al.  Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects. , 2006, Journal of clinical periodontology.

[18]  J. Wennström,et al.  Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects. , 2006, Journal of periodontology.

[19]  A. Sculean,et al.  Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate. , 2005, Journal of periodontology.

[20]  C. Cafiero,et al.  Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study. , 2005, The International journal of periodontics & restorative dentistry.

[21]  N. Lang,et al.  Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects. , 2004, Journal of clinical periodontology.

[22]  B. Boyan,et al.  The use of enamel matrix derivative in the treatment of periodontal defects: a literature review and meta-analysis. , 2004, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[23]  M. Mills,et al.  Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans. , 2004, Journal of periodontology.

[24]  F. Schwarz,et al.  Five-year results following treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. , 2004, Journal of clinical periodontology.

[25]  R. Parodi,et al.  Treatment of intrabony pockets with Emdogain: results at 36 months. , 2004, The International journal of periodontics & restorative dentistry.

[26]  G. Zucchelli,et al.  Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: a comparative controlled clinical trial. , 2003, Journal of periodontology.

[27]  Markus B Hürzeler,et al.  Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study. , 2003, Journal of clinical periodontology.

[28]  M. Reynolds,et al.  A retrospective case series comparing the use of demineralized freeze-dried bone allograft and freeze-dried bone allograft combined with enamel matrix derivative for the treatment of advanced osseous lesions. , 2002, Journal of periodontology.

[29]  E. Reich,et al.  Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio-Oss) for the treatment of intrabony periodontal defects in humans. , 2002, The International journal of periodontics & restorative dentistry.

[30]  J. Mellonig,et al.  Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. , 2002, Journal of periodontology.

[31]  N. Lang,et al.  Enamel matrix proteins in the regenerative therapy of deep intrabony defects. , 2002, Journal of clinical periodontology.

[32]  A. Sculean,et al.  Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. , 2002, Journal of periodontology.

[33]  M. Pietruska.  A comparative study on the use of Bio-Oss and enamel matrix derivative (Emdogain) in the treatment of periodontal bone defects. , 2001, European journal of oral sciences.

[34]  E. Reich,et al.  Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. , 2001, Journal of clinical periodontology.

[35]  A. Sculean,et al.  Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative (Emdogain). , 2000, The International journal of periodontics & restorative dentistry.

[36]  T. Karring,et al.  Treatment of intrabony defects with guided tissue regeneration and enamel-matrix-proteins. An experimental study in monkeys. , 2000, Journal of clinical periodontology.

[37]  Z. Aleksic,et al.  A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. , 2000, Journal of periodontology.

[38]  M. Tonetti,et al.  The simplified papilla preservation flap. A novel surgical approach for the management of soft tissues in regenerative procedures. , 1999, The International journal of periodontics & restorative dentistry.

[39]  J. Wennström,et al.  The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. , 1999, Journal of clinical periodontology.

[40]  T. Karring,et al.  Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. , 1999, Journal of periodontal research.

[41]  G. Daculsi,et al.  Biphasic calcium phosphate/hydrosoluble polymer composites: a new concept for bone and dental substitution biomaterials. , 1999, Bone.

[42]  J. Mellonig.  Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologic case report. , 1999, The International journal of periodontics & restorative dentistry.

[43]  L. Heijl.  Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. , 1997, Journal of clinical periodontology.

[44]  L. Hammarström,et al.  Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. , 1997, Journal of clinical periodontology.

[45]  G. Heden,et al.  Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. , 1997, Journal of clinical periodontology.

[46]  E. Machtei,et al.  Outcome variables for the study of periodontal regeneration. , 1997, Annals of periodontology.

[47]  C. Mangano,et al.  Clinical and histologic aspects of biphasic calcium phosphate ceramic (BCP) used in connection with implant placement. , 1996, Biomaterials.

[48]  M. Tonetti,et al.  The modified papilla preservation technique. A new surgical approach for interproximal regenerative procedures. , 1995, Journal of periodontology.

[49]  K. Lynch,et al.  Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/beta TCP in periodontal osseous defects. , 1992, Journal of periodontology.

[50]  J. Egelberg,et al.  Healing after treatment of periodontal intraosseous defects. V. Effect of root planing versus flap surgery. , 1985, Journal of clinical periodontology.

[51]  J. Egelberg,et al.  Healing after treatment of periodontal intraosseous defects. I. Comparative study of clinical methods. , 1981, Journal of clinical periodontology.

[52]  Y. Tu,et al.  Do bone grafts or barrier membranes provide additional treatment effects for infrabony lesions treated with enamel matrix derivatives? A network meta-analysis of randomized-controlled trials. , 2010, Journal of clinical periodontology.

[53]  F. Schwarz,et al.  Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. , 2008, Journal of clinical periodontology.

[54]  S. Froum,et al.  A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study. , 2001, Journal of periodontology.

[55]  R. Scott,et al.  Long-Term Results , 2001 .